Stoker's Proud Launches Affordable Tobacco Products
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 16 2026
0mins
Should l Buy TPB?
Source: Yahoo Finance
- New Brand Launch: Stoker's Proud, as a new sub-brand of Stoker's, aims to meet consumer demand for high-quality, affordable tobacco products, marking a significant expansion in the brand's market presence.
- Product Features: The brand utilizes 100% American-grown tobacco and employs traditional curing and flavoring processes, offering a distinct long cut tobacco experience that enhances product diversity within the portfolio.
- Market Positioning: Stoker's Proud meets consumer needs for convenience and familiarity by providing a classic 1.2-ounce can format while maintaining the brand's core values and quality standards.
- Brand Heritage: With over 85 years of history, Stoker's holds the leading position in the chewing tobacco category, and the launch of Stoker's Proud further solidifies its dominance in the moist snuff market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TPB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TPB
Wall Street analysts forecast TPB stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 79.880
Low
110.00
Averages
116.67
High
120.00
Current: 79.880
Low
110.00
Averages
116.67
High
120.00
About TPB
Turning Point Brands, Inc. is a manufacturer, marketer and distributor of branded consumer products. It sells a range of products to adult consumers, consisting of staple products under the brands Zig-Zag and Stoker’s. Its segments include Zig-Zag Products (Zig-Zag) and Stoker’s Products (Stoker’s). Zig-Zag principally markets and distributes rolling papers, tubes, and related products; finished cigars and make-your-own cigar wraps, and other accessories. It introduced Zig-Zag ‘Rillo-sized wraps, which are similar in size to cigarillos, a type of machine-made cigars. Stoker’s manufactures and markets moist snuff tobacco (MST) and contract for and market FRE, its modern oral product and contract for and market loose-leaf chewing tobacco products. Its products are available in approximately 200,000 in the United States retail locations which, with the addition of retail stores in Canada, brings its total North American retail presence to an estimated 220,000 points of distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Turning Point Brands Schedules Q1 2026 Earnings Call
- Earnings Call Announcement: Turning Point Brands has announced a conference call scheduled for May 7, 2026, at 8:30 a.m. Eastern Time to review its first quarter financial results, aimed at providing analysts and investors with insights into its financial performance and future outlook.
- Participation Details: Interested analysts and professional investors can register to participate via the U.S. toll-free number (800) 715-9871 or the international number (646) 307-1963, with a recommendation to dial in at least ten minutes early to ensure smooth access to the call.
- Live Webcast: The earnings call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website, allowing investors who cannot dial in to still access the information shared during the call.
- Replay Availability: A replay of the conference call will be available on the company’s website two hours after the call concludes, ensuring that all stakeholders can access the key content and insights discussed during the meeting.
See More
Turning Point Brands Partners with TKO Group for Marketing Deal
- Stock Surge: Turning Point Brands' stock soared over 10% on the day following the announcement of a multi-year marketing partnership with TKO Group, indicating strong shareholder approval and potential for enhanced market performance.
- Partner Background: TKO Group, owner of major sports entertainment assets like UFC and WWE, will promote Turning Point's FRE nicotine pouches across six of its brands, significantly increasing Turning Point's reach in the adult consumer market.
- Marketing Strategy: The partnership involves marketing FRE through what TKO describes as 'custom integrations and experiences,' a strategy likely to attract more adult consumers and boost sales and brand awareness.
- Missing Major Brand: Notably absent from TKO's announcement was WWE, the largest revenue source for TKO, suggesting that Turning Point may be exploring a separate marketing deal with TKO to further enhance its market presence.
See More
FRE Partners with TKO for Multi-Year Collaboration
- Partnership Formation: TKO Group Holdings has established a multi-year partnership with FRE Nicotine Pouches, making FRE the official partner across six TKO properties including UFC, Zuffa Boxing, and PBR, which is expected to significantly enhance brand visibility and market penetration.
- Target Audience Reach: With over 90% of UFC's audience being adults, FRE is leveraging this platform for responsible marketing of adult consumer products, which is anticipated to attract more existing nicotine users and enhance brand loyalty.
- Innovative Marketing Activities: FRE will conduct exclusive fan activations and custom content at venues like the UFC Octagon and Zuffa Boxing ring, aiming to boost user engagement through on-site experiences, thereby driving sales growth and brand recognition.
- Product Advantages Highlighted: FRE's nicotine pouches offer a range of strengths from 3-15mg and feature pre-primed moisture technology, catering to diverse consumer needs, which is expected to further solidify its leadership position in the premium nicotine product market.
See More
Turning Point Brands Stock Falls 15.5% Due to FDA Approval Delays
- Significant Stock Decline: Turning Point Brands' stock fell 15.5% this week, currently priced at $72.16 with a market cap of $1.4 billion, reflecting market concerns over FDA approval delays that could impact future revenue growth.
- Nicotine Pouch Business Growth: Despite facing FDA approval delays, Turning Point Brands' nicotine pouch segment achieved a remarkable 266% year-over-year growth last quarter, generating $41.3 million in revenue, which constitutes 34% of total company revenues, indicating strong market potential.
- Market Reaction Analysis: The FDA's cautious stance on nicotine pouch approvals has led investors to worry about the company's growth prospects, resulting in a 50% decline from its peak stock price, which may affect the company's financing capabilities and market confidence.
- Investment Opportunity Assessment: Despite short-term challenges, Turning Point Brands' stable revenue streams could still make it attractive in the long run; if investors believe the FDA concerns are merely temporary, the current stock price may present a buying opportunity.
See More
Turning Point Brands Shares Plunge 50% Amid FDA Concerns
- FDA Approval Delays: The FDA's slow approval process for new nicotine pouch types due to safety concerns for children has led to a 15.5% drop in Turning Point Brands' stock this week, with shares down 50% from their highs, significantly impacting market confidence in the company.
- Slowing Revenue Growth: Despite the Fre brand's nicotine pouch revenue growing 266% year-over-year to $41.3 million, accounting for 34% of total company revenues, the FDA's delays could hinder future revenue expectations, with guidance calling for net revenue of $180 million to $190 million for the category by 2026.
- Market Reaction: Turning Point Brands currently has a market cap of $1.3 billion, and while it maintains steady revenue from traditional products like rolling papers and chewing tobacco, investor reactions to the FDA's negative news have caused further declines in stock price.
- Investor Confidence Shaken: Following disappointing earnings reports, Turning Point Brands was not included in The Motley Fool's list of the 10 best stocks to buy, reflecting skepticism about its future growth potential and potentially affecting investor purchasing decisions.
See More
Tobacco Stocks Plummet Amid FDA Approval Concerns
- Regulatory Approval Delays: A Reuters report indicates that FDA scientists are hesitant to authorize oral nicotine products, leading to a sell-off among tobacco investors, with Turning Point Brands' stock plummeting over 14% in a single trading session, reflecting market concerns over new product introductions.
- Child Health Risks: The FDA scientists express worries about the potential risks these nicotine products pose to new users, particularly children, making it increasingly difficult for such products to gain approval and further impacting Turning Point's market outlook.
- Product Line Obstacles: Turning Point's applications for new versions of its Stoker's chewing tobacco and the Fre nicotine pouch products are currently in regulatory limbo, and continued delays from the FDA could severely hinder the company's product launches and revenue growth.
- Bleak Industry Outlook: Due to regulatory challenges, Turning Point and other tobacco companies may face a tough period ahead, with diminished investor confidence in their future growth, prompting a cautious approach to investments in this sector.
See More
Turning Point Brands Schedules Q1 2026 Earnings Call
- Earnings Call Announcement: Turning Point Brands has announced a conference call scheduled for May 7, 2026, at 8:30 a.m. Eastern Time to review its first quarter financial results, aimed at providing analysts and investors with insights into its financial performance and future outlook.
- Participation Details: Interested analysts and professional investors can register to participate via the U.S. toll-free number (800) 715-9871 or the international number (646) 307-1963, with a recommendation to dial in at least ten minutes early to ensure smooth access to the call.
- Live Webcast: The earnings call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website, allowing investors who cannot dial in to still access the information shared during the call.
- Replay Availability: A replay of the conference call will be available on the company’s website two hours after the call concludes, ensuring that all stakeholders can access the key content and insights discussed during the meeting.
See More
Turning Point Brands Partners with TKO Group for Marketing Deal
- Stock Surge: Turning Point Brands' stock soared over 10% on the day following the announcement of a multi-year marketing partnership with TKO Group, indicating strong shareholder approval and potential for enhanced market performance.
- Partner Background: TKO Group, owner of major sports entertainment assets like UFC and WWE, will promote Turning Point's FRE nicotine pouches across six of its brands, significantly increasing Turning Point's reach in the adult consumer market.
- Marketing Strategy: The partnership involves marketing FRE through what TKO describes as 'custom integrations and experiences,' a strategy likely to attract more adult consumers and boost sales and brand awareness.
- Missing Major Brand: Notably absent from TKO's announcement was WWE, the largest revenue source for TKO, suggesting that Turning Point may be exploring a separate marketing deal with TKO to further enhance its market presence.
See More
FRE Partners with TKO for Multi-Year Collaboration
- Partnership Formation: TKO Group Holdings has established a multi-year partnership with FRE Nicotine Pouches, making FRE the official partner across six TKO properties including UFC, Zuffa Boxing, and PBR, which is expected to significantly enhance brand visibility and market penetration.
- Target Audience Reach: With over 90% of UFC's audience being adults, FRE is leveraging this platform for responsible marketing of adult consumer products, which is anticipated to attract more existing nicotine users and enhance brand loyalty.
- Innovative Marketing Activities: FRE will conduct exclusive fan activations and custom content at venues like the UFC Octagon and Zuffa Boxing ring, aiming to boost user engagement through on-site experiences, thereby driving sales growth and brand recognition.
- Product Advantages Highlighted: FRE's nicotine pouches offer a range of strengths from 3-15mg and feature pre-primed moisture technology, catering to diverse consumer needs, which is expected to further solidify its leadership position in the premium nicotine product market.
See More
Turning Point Brands Stock Falls 15.5% Due to FDA Approval Delays
- Significant Stock Decline: Turning Point Brands' stock fell 15.5% this week, currently priced at $72.16 with a market cap of $1.4 billion, reflecting market concerns over FDA approval delays that could impact future revenue growth.
- Nicotine Pouch Business Growth: Despite facing FDA approval delays, Turning Point Brands' nicotine pouch segment achieved a remarkable 266% year-over-year growth last quarter, generating $41.3 million in revenue, which constitutes 34% of total company revenues, indicating strong market potential.
- Market Reaction Analysis: The FDA's cautious stance on nicotine pouch approvals has led investors to worry about the company's growth prospects, resulting in a 50% decline from its peak stock price, which may affect the company's financing capabilities and market confidence.
- Investment Opportunity Assessment: Despite short-term challenges, Turning Point Brands' stable revenue streams could still make it attractive in the long run; if investors believe the FDA concerns are merely temporary, the current stock price may present a buying opportunity.
See More
Turning Point Brands Shares Plunge 50% Amid FDA Concerns
- FDA Approval Delays: The FDA's slow approval process for new nicotine pouch types due to safety concerns for children has led to a 15.5% drop in Turning Point Brands' stock this week, with shares down 50% from their highs, significantly impacting market confidence in the company.
- Slowing Revenue Growth: Despite the Fre brand's nicotine pouch revenue growing 266% year-over-year to $41.3 million, accounting for 34% of total company revenues, the FDA's delays could hinder future revenue expectations, with guidance calling for net revenue of $180 million to $190 million for the category by 2026.
- Market Reaction: Turning Point Brands currently has a market cap of $1.3 billion, and while it maintains steady revenue from traditional products like rolling papers and chewing tobacco, investor reactions to the FDA's negative news have caused further declines in stock price.
- Investor Confidence Shaken: Following disappointing earnings reports, Turning Point Brands was not included in The Motley Fool's list of the 10 best stocks to buy, reflecting skepticism about its future growth potential and potentially affecting investor purchasing decisions.
See More
Tobacco Stocks Plummet Amid FDA Approval Concerns
- Regulatory Approval Delays: A Reuters report indicates that FDA scientists are hesitant to authorize oral nicotine products, leading to a sell-off among tobacco investors, with Turning Point Brands' stock plummeting over 14% in a single trading session, reflecting market concerns over new product introductions.
- Child Health Risks: The FDA scientists express worries about the potential risks these nicotine products pose to new users, particularly children, making it increasingly difficult for such products to gain approval and further impacting Turning Point's market outlook.
- Product Line Obstacles: Turning Point's applications for new versions of its Stoker's chewing tobacco and the Fre nicotine pouch products are currently in regulatory limbo, and continued delays from the FDA could severely hinder the company's product launches and revenue growth.
- Bleak Industry Outlook: Due to regulatory challenges, Turning Point and other tobacco companies may face a tough period ahead, with diminished investor confidence in their future growth, prompting a cautious approach to investments in this sector.
See More
